Vaccine News and Research

Latest Vaccine News and Research

Socioeconomic privilege and political ideology correlate to racial disparities in COVID-19 vaccination

Income, educational attainment, and political ideology all play into racial disparities in vaccination rates that have left African Americans more vulnerable to COVID-19, finds new research from the Center for Health Information and Decision Systems at the University of Maryland's Robert H. Smith School of Business.

11 Aug 2021

CDC releases new data on the safety of COVID-19 vaccines in pregnant people

CDC has released new data on the safety of the COVID-19 vaccines in pregnant people and is recommending all people 12 years of age and older get vaccinated against COVID-19.

11 Aug 2021

COVID-19 vaccine likely protects people living with HIV, study shows

A Johns Hopkins Medicine research team has shown that people living with the human immunodeficiency virus (HIV) are likely to be protected against SARS-CoV-2, the virus that causes COVID-19, if they are fully vaccinated.

11 Aug 2021

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite.

11 Aug 2021

Public favors masks in classrooms but balks at mandating vaccinations for students

As the spread of the delta variant threatens the safety of classrooms, a poll released Wednesday found nearly two-thirds of parents support schools' requiring unvaccinated students age 5 or older and teachers to wear masks.

11 Aug 2021

Study finds high risk groups rejecting the COVID-19 vaccine in England

To increase COVID-19 vaccination rates, public health officials must understand who is refusing the vaccines. New research led by Ben Goldacre from the University of Oxford found that about 2% of people considered high-risk did not want the vaccine when offered. In addition, vaccination refusal in priority groups was most common among English people who are Black, South Asian, or from lower socioeconomic areas.

11 Aug 2021

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

World Health Organization (WHO) guidelines indicate the optimal timing of vaccination among specific groups based on the probability of infection and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), e.g., health care workers providing direct care or acute disease and death (e.g., older people, organ transplant recipients).

11 Aug 2021

COVID-19 booster shot in autumn will effectively protect against existing and future variants

Scientists at the University of Nottingham have confirmed that an autumn 'booster' dose of a Covid-19 vaccine will be an effective way to protect people from existing, and potentially future, variants of concern.

11 Aug 2021

COVID-19 vaccines offer better protection than natural immunity alone

Now, the U.S. Centers for Disease Control and Prevention (CDC) reports that among people who were previously infected with SARS-CoV-2, those who were still unvaccinated are more likely to be reinfected than those fully vaccinated after prior infection.

11 Aug 2021

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Scientists from Germany and Belgium have recently described the immunogenicity of a plant-based virus-like particle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine induces robust antibody and T cell responses for at least 6 months. Moreover, the vaccine demonstrates potent neutralizing efficacy against the B.1.1.7, B.1.351, and P1 variants of SARS-CoV-2.

11 Aug 2021

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

A new study demonstrates that the two mRNA vaccines have widely varying efficacies against the SARS-CoV-2 Delta variant.

10 Aug 2021

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

A new study explores the polyclonal antibody response to SARS-CoV-2 in greater detail.

10 Aug 2021

Study shows efficacy of gamma irradiation of SARS-CoV-2 vaccine candidate in mouse model

A new study reports a more rapid method of viral inactivation in an effort to increase the appeal of inactivated viral vaccines against the COVID-19 pandemic.

10 Aug 2021

Natural vs. vaccine-induced COVID-19 immunity

A new paper discusses the protection offered by immunity against COVID-19 following vaccination as compared to natural infection.

10 Aug 2021

Patient laments on not getting the COVID-19 vaccine

Saul Torres considers himself lucky to be alive after contracting COVID-19 and suffering from a rare neurological condition.

10 Aug 2021

Comparative scoring system suggests possibility of global COVID-19 eradication

The global eradication of COVID-19 is probably feasible, and more so than it is for polio, although considerably less so than it was for smallpox, suggests a comparative score of technical, sociopolitical, and economic factors for all three infections, published in the online journal BMJ Global Health.

10 Aug 2021